RC Outsourcing recalled 2,669 bevacizumab intravitreal syringes distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Stop using the product immediately and contact RC Outsourcing or your healthcare provider for guidance. Recall notices will be sent by letter.
Lack of assurance of sterility.
Consumers and healthcare providers should stop using this product immediately. Contact RC Outsourcing, LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Bevacizumab intravitreal injections are used to treat retinal diseases in adults and are prepared for hospital or office use. They are administered by ophthalmologists in a clinical setting.
A lack of sterility can result in contamination and eye infections, including serious conditions like endophthalmitis, requiring medical care.
This recall is not part of a broader industry pattern.
Hospitals and clinics must review stock, pause administrations, and coordinate with suppliers. The recall involves 2,669 syringes distributed nationwide, potentially affecting patient care workflows and budgets.
FDA enforcement page for D-0003-2026 and recall notices: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0003-2026
Recall processing timelines vary; follow RC Outsourcing guidance. Typical recall-related refunds or replacements, when offered, can take several weeks
Retain all recall notices, packaging photos, lot numbers, communication with RC Outsourcing LLC, and records of stock disposition.
Bevacizumab intravitreal syringe, 0.25 mL total volume (1.75 mg/0.07 mL). Lot numbers being recalled: 20250708-768A26, 20250715-944DF2, 20250722-55C603, 20250722-5DC113. Sold to hospitals and clinics nationwide in the United States. Recall date: 2025-09-22. Quantity: 2,669 syringes. Price: Unknown.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of